KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

How does the $0.18 quarterly dividend compare to the company's historical dividend payouts and growth rate? What is the dividend yield based on the current share price, and how does it compare to industry peers? What is the payout ratio relative to KPTI's earnings and cash flow, and is it sustainable? How does the dividend declaration affect the stock’s ex‑dividend date and potential short‑term price movement? What is the market’s expectation for the dividend, and did this announcement surprise analysts? What is the company’s cash position and liquidity to support the dividend and potential future payouts? How does this dividend declaration impact the valuation multiples (e.g., P/E, dividend discount model) for the stock? Are there any changes in the company’s guidance or capital allocation plan that accompany this dividend? What is the tax treatment of this dividend for different investor types, particularly in non‑U.S. jurisdictions? How does KPTI’s dividend yield compare to its main competitors in the same sector? What are the potential risks (e.g., cash flow constraints, debt levels) that could affect future dividend payments? Are there any upcoming corporate events (e.g., earnings releases, M&A activity) that could influence the dividend’s impact on the stock price?